Articles
Raising Awareness for Brain Tumor Research
Articles Blog FeaturedMay is Brain Tumor Awareness Month. In the United States, an estimated 700,000 people are living with a primary brain tumor and 79,000 more will be diagnosed this year. GliomasRead more- Articles HighlightsScientific American’s Custom Media division hosted a unique salon-style event in collaboration with Immunomic Therapeutics on Monday, February 12th in the heart of Manhattan’s Times Square. The forum, Hot Topics in Biotech:Read more
How Astellas is Working to Change Allergy Prevention through Partnership with Immunomic Therapeutics
Articles Featured HighlightsRead how Astellas is working to address a high unmet medical need with first-of-its-kind allergy vaccine development through an innovative partnership. The following article was authored by Astellas and published onRead moreThe Fight Against Cancer Is Increasingly Personal
Articles Highlights PressScientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures.Read moreMd. is developing the next generation of life-saving vaccines
Articles Blog PressSia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.htmlRead moreWhat’s Behind the Fear of Vaccines?
Articles Blog FeaturedA closer look at the social, cultural and political issues influencing immunization This article was produced for Immunomic Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.Read moreImmunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
ArticlesMay 15, 2017 Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines Immunomic Therapeutics negotiated an exclusive license to Annias Immunotherapeutics’ platform covering technology for targeting cytomegalovirus (CMV) antigensRead moreWilliam Hearl: ‘If we figure out a way to cure a cancer . . . the money will find us’
ArticlesWilliam Hearl: ‘If we figure out a way to cure a cancer . . . the money will find us’ William Hearl is founder and chief executive officer of ImmunomicRead moreBioWorld’s PARTNER in FOCUS: Immunomic Therapeutics Inc.
ArticlesTHE REMARKABLE SCIENCE BEHIND LAMP TECHNOLOGY – AND ITS POTENTIAL TO TREAT HUMAN DISEASE http://dev.immunomix.com/old/wp-content/uploads/2016/05/Partner_in_Focus_ITI.pdf The body’s own immune system is its best defense against everything from allergies to cancer –Read moreThe Next Generation of DNA Vaccines Is Poised to Transform the Healthcare Landscape
ArticlesThe Next Generation of DNA Vaccines Is Poised to Transform the Healthcare Landscape By Teri Heiland October 13, 2014 | Contributed Commentary | Over the last several decades, the advent of biotechnology hasRead more
